Download Full eBooks in PDF
Target Regimen Profiles For Tuberculosis Treatment 2023 Update Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Target Regimen Profiles For Tuberculosis Treatment 2023 Update book. This book definitely worth reading, it is an incredibly well-written.
Author : World Health Organization
Publisher : World Health Organization
Page : 92 pages
File Size : 43,5 Mb
Release : 2023-11-01
Category : Medical
ISBN : 9789240081512
Author : World Health Organization
Publisher : World Health Organization
Page : 50 pages
File Size : 47,8 Mb
Release : 2023-10-17
Category : Medical
ISBN : 9789240081178
Author : World Health Organization
Publisher : Unknown
Page : 60 pages
File Size : 41,5 Mb
Release : 1993
Category : Antitubercular agents
ISBN : UIUC:30112118366886
Author : World Health Organization
Publisher : World Health Organization
Page : 15 pages
File Size : 44,7 Mb
Release : 2023-05-29
Category : Medical
ISBN : 9789240074705
Author : King K. Holmes,Stefano Bertozzi,Barry R. Bloom,Prabhat Jha
Publisher : World Bank Publications
Page : 506 pages
File Size : 43,7 Mb
Release : 2017-11-06
Category : Medical
ISBN : 9781464805257
Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.
Author : World Health Organization
Publisher : World Health Organization
Page : 72 pages
File Size : 55,9 Mb
Release : 2024-05-17
Category : Medical
ISBN : 9789240093461
Author : Ben Gold,Helena Ingrid Boshoff,Digby Warner
Publisher : Frontiers Media SA
Page : 269 pages
File Size : 40,6 Mb
Release : 2023-06-08
Category : Science
ISBN : 9782832526156
Author : Anonim
Publisher : World Health Organization
Page : 32 pages
File Size : 48,6 Mb
Release : 2022-01-20
Category : Medical
ISBN : 9789240040250
Author : World Health Organization
Publisher : Unknown
Page : 0 pages
File Size : 48,5 Mb
Release : 2017-06
Category : Medical
ISBN : 9241550007
The update of the Guidelines for Treatment of Drug-susceptible Tuberculosis and Patient Care is important in the context of the End TB Strategy, which recommends treatment and patient support for all people with TB. This update aims to use the best available evidence on the treatment of drug-susceptible TB and interventions to ensure adequate patient care and support in order to inform policy decisions made in these technical areas by national TB control program managers, national policy-makers, and medical practitioners in a variety of geographical, economic, and social settings. The objectives of these updated guidelines are to provide updated recommendations based on newly emerged evidence on the treatment of drug-susceptible TB and patient care as well as provide a summary of changes in the new guidelines with all the existing and valid WHO recommendations on the treatment of drug-susceptible TB and TB patient care. The key audience for these guidelines are policy-makers in ministries of health or managers of national TB programs who formulate country-specific TB treatment guidelines or who plan TB treatment programs. In addition, health professionals - including doctors, nurses, and educators working both in government services and nongovernmental organizations, such as technical agencies that are treating patients and organizing treatment services - will find these guidelines to be useful.
Author : World Health Organization
Publisher : World Health Organization
Page : 72 pages
File Size : 48,9 Mb
Release : 2022-04-30
Category : Medical
ISBN : 9789240048126
Between 2011 and 2019, WHO has developed and issued evidence-based policy recommendations on the treatment and care of patients with DR-TB. These policy recommendations have been presented in several WHO documents and their associated annexes, including the WHO Consolidated Guidelines on Drug Resistant Tuberculosis Treatment, issued by WHO in March 2019. The policy recommendations in each of these guidelines have been developed by WHO-convened Guideline Development Groups, using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach to summarize the evidence, and formulate policy recommendations and accompanying remarks. The present WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment includes a comprehensive set of WHO recommendations for the treatment and care of DR-TB. The document includes two new recommendations, one on the composition of shorter regimens and one on the use of the BPaL regimen (i.e. bedaquiline, pretomanid and linezolid). In addition, the consolidated guidelines include existing recommendations on treatment regimens for isoniazid-resistant TB and MDR/RR-TB, including longer regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), the use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care. The guidelines are to be used primarily in national TB programmes, or their equivalents in Ministries of Health, and for other policy-makers and technical organizations working on TB and infectious diseases in public and private sectors and in the community.
Author : World Health Organization
Publisher : Unknown
Page : 0 pages
File Size : 42,9 Mb
Release : 2016
Category : Medical
ISBN : 924156539X
This global tuberculosis report is the first to be produced in the era of the SDGs and the End TB Strategy. It provides an assessment of the TB epidemic and progress in TB diagnosis, treatment, and prevention efforts as well as an overview of TB-specific financing and research. It also discusses the broader agenda of universal health coverage, social protection, and other SDGs that have an impact on health. Data was available for 202 countries and territories that account for over 99% of the world's population and TB cases.
Author : World Health Organization
Publisher : Unknown
Page : 294 pages
File Size : 43,9 Mb
Release : 2019-08-12
Category : Electronic
ISBN : 9241565713
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of recommended global TB strategies and targets endorsed by WHO?s Member States, broader development goals set by the United Nations (UN) and targets set in the political declaration at the first UN high-level meeting on TB (held in September 2018). The 2019 edition of the global TB report was released on 17 October 2019. The data in this report are updated annually. Please note that direct comparisons between estimates of TB disease burden in the latest report and previous reports are not appropriate. The most recent time-series of estimates are published in the 2019 global TB report.
Author : World Health Organization
Publisher : World Health Organization
Page : 204 pages
File Size : 40,9 Mb
Release : 2015
Category : Medical
ISBN : 9789241565059
Chapter 1. Introduction -- chapter 2. Disease burden and 2015 targets assessment -- chapter 3. TB case notifications and treatment outcomes -- chapter 4. Drug-resistant TB -- chapter 5. Diagnostics and laboratory strengthening -- chapter 6. Addressing the co-epidemics of TB and HIV -- chapter 7. Financing -- chapter 8. Research and development -- Annexes.
Author : Giovanni Battista Migliori,Mario C. Raviglione
Publisher : Springer Nature
Page : 416 pages
File Size : 54,6 Mb
Release : 2021-07-26
Category : Medical
ISBN : 9783030667030
This textbook covers the full spectrum of tuberculosis-related topics in a comprehensive yet easy-to-follow, readily accessible format. Filling a significant gap in tuberculosis literature, it addresses tuberculosis sensu latu, mirroring the content of the London Queen Mary University tuberculosis Diploma. Covering all aspects related to this condition, from prevention, diagnosis and treatment to public and global health, the book provides a broad overview of tuberculosis management. Further, it includes a wealth of case studies and exercises, making it an essential guide for all staff involved in tuberculosis management. Written by an international and interdisciplinary panel of experts, the book appeals to a broad readership including students, postdoctoral fellows, clinicians, researchers, and nurses, as well as public health officers working in tuberculosis control programs.
Author : World Health Organization
Publisher : Unknown
Page : 0 pages
File Size : 50,8 Mb
Release : 2015-04-20
Category : Medical
ISBN : 9241501588
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response to the Sixty-second World Health Assembly's resolution on prevention and control of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Resolution WHA62.15, adopted in 2009, calls on Member States to develop a comprehensive framework for the management and care of patients with drug-resistant TB. The recommendations contained in these guidelines address the most topical questions concerning the programmatic management of drug-resistant TB: case-finding, multidrug resistance, treatment regimens, monitoring the response to treatment, and selecting models of care. The guidelines primarily target staff and medical practitioners working in TB treatment and control, and partners and organizations providing technical and financial support for care of drug-resistant TB in settings where resources are limited.
